Society of Breast Imaging Cancels 2020 Conference
The Society of Breast Imaging (SBI) announced it has canceled its annual symposium with the American College of Radiology due to concerns over the growing COVID-19 outbreak. The meeting had been planned for April 16-19 in Denver.
"Protecting the health and well-being of all attendees is our greatest concern," said SBI President Margarita L. Zuley, M.D., in a written statement. "Canceling the Symposium required much discussion and deep consideration. It was a decision we came to reluctantly."
The organization made its decision after reviewing the World Health Organization's evaluations, as well as the ongoing amount of research being published on the impact of the virus. Full refunds will be made available to all registered attendees over the next few weeks, according to the press announcement.
There are no plans to reschedule the meeting for later this year. Instead, the next meeting is planned for April 8-11, 2021, in Savannah, Ga.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
